✦ LIBER ✦

PCN118 COST EFFECTIVENESS OF CETUXIMAB IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER: DESCRIPTION OF A NICE SUBMISSION

✍ Scribed by SG Eggington; D Garrell; I Griebsch; Y Samyshkin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN19 COST EFFECTIVENESS OF CETUXIMAB IN

✍ D Garrell; I Griebsch; Y Samyshkin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN3 Cetuximab for the First-Line Treatm

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Rodriguez, R.; Beltran, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN71 Cost-Effectiveness Analysis of Cet

✍ V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ibáñez de Cáceres; Á 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN87 The Cost Effectiveness of Cetuxima

✍ Perard, R.; Samyshkin, Y.; Guillermin, A.L.G. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cetuximab adds benefit in first-line tre

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

NICE guidance on cetuximab, bevacizumab,

✍ Fiona Rinaldi; Elisabeth George; Amanda I Adler 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 43 KB